Trials / Sponsors / InterveXion Therapeutics, LLC
InterveXion Therapeutics, LLC
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Multiple-Dose Study to Evaluate the Safety and Efficacy of IXT-m200 Methamphetamine-dependence, Methamphetamine Abuse | Phase 2 | 2022-06-09 |
| Completed | Safety, Tolerability, and Pharmacokinetics of IXT-m200 Healthy | Phase 1 | 2021-10-25 |
| Terminated | Meth-OD: A Study of IXT-m200 in Patients With Toxicity From Methamphetamine Overdose Methamphetamine Intoxication (Disorder) | Phase 2 | 2021-06-30 |
| Completed | Study of Antibody for Methamphetamine Outpatient Therapy Methamphetamine-dependence, Methamphetamine Abuse | Phase 1 / Phase 2 | 2018-05-03 |
| Completed | Safety Study of Ch-mAb7F9 for Methamphetamine Abuse Methamphetamine Abuse | Phase 1 | 2012-04-01 |